Valley NewsCompany
· 5d
The official news channel of Valley
Swiss AI startup Atlast Bio raises $12.5M to simulate drug trials. The Creandum-led round will fund virtual-patient simulations designed to replace parts of Phase II testing, which can cost over $100M, take two to three years and see about 70% of drugs fail. The deal highlights growing investor interest in AI tools targeting pharmaceutical R&D bottlenecks.
🔗 https://sifted.eu/articles/talent-top...
#ClimeTech #VC #EuropeanTech
0
2